Trelegy ellipta 100-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DB26FGLYL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $60,286
Award facts
- Contract value 100% obligated
- $60,285.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, PA, received a $60,285.66 delivery order from the Defense Logistics Agency (DLA) on October 17, 2025, for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count). This firm fixed-price, competitively awarded contract is scheduled for completion by October 20, 2025, and represents a child order under the company's larger pharmaceutical supply agreement. The award carries no set-aside designation, indicating AmerisourceBergen competed against other qualified vendors in an open procurement process.
This delivery order falls under AmerisourceBergen's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a global pharmaceutical support vehicle supplying military healthcare systems with a broad portfolio of medications, vaccines, and medical supplies across multiple therapeutic domains. TRELEGY ELLIPTA is a combination respiratory medication used in chronic obstructive pulmonary disease treatment, reflecting the breadth of pharmaceutical commodities the company provides to support Defense Health Agency and other federal healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DB26FGLYL?
SPE2DB26FGLYL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 17, 2025.
How much is contract SPE2DB26FGLYL worth?
The government has obligated $60,286 on SPE2DB26FGLYL.
Is contract SPE2DB26FGLYL an order under another contract?
Yes. SPE2DB26FGLYL is a delivery order under SPE2DB24D2216, an indefinite delivery contract.
Was contract SPE2DB26FGLYL competed?
The extent of competition for SPE2DB26FGLYL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award